NCT00934973View on ClinicalTrials.gov

Management of Irritable Bowel Syndrome in Primary Care (MIBS Trial)

PHASE4CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

October 31, 2011

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

mebeverine

overencapsulated mebeverine 135 mg tds for 6 weeks

DRUG

methylcellulose

overencapsulated methylcellulose 3 tablets bd for 6 weeks

DRUG

placebo

overencapsulated placebo tablets 1 tds for 6 weeks

BEHAVIORAL

CBT website with support

cognitive behavioral therapy with nurse telephone session and email support

BEHAVIORAL

No website

No CBT website

BEHAVIORAL

CBT website with minimal support

Trial Locations (1)

SO17 1JB

University of Southampton, Southampton

Sponsors

Lead Sponsor

Hazel Everitt
All Listed Sponsors
collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

Hazel Everitt

OTHER

NCT00934973 - Management of Irritable Bowel Syndrome in Primary Care (MIBS Trial) | Biotech Hunter | Biotech Hunter